middle.news
Elixinol to Divest US Business for A$465,000 Amid Regulatory Uncertainty
3:36pm on Monday 31st of August, 2026 AEST
•
Health and Wellness
Read Story
Elixinol to Divest US Business for A$465,000 Amid Regulatory Uncertainty
3:36pm on Monday 31st of August, 2026 AEST
Key Points
Binding offer received from Ananda Health for US business
Headline consideration of A$465,000 including earn-outs and contingencies
Divestment reduces regulatory risk exposure in US hemp market
Focus shifts to Australian health and wellness portfolio
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Elixinol Wellness (ASX:EXL)
OPEN ARTICLE